Lipid peroxides and antioxidant enzymes in cisplatin-induced chronic nephrotoxicity in rats

Mediators of Inflammation

Volumn 2005, Issue 3, 2005, Pages 139-143

  González, Ricardo ^a   Romay, Cheyla ^a   Borrego, Aluet ^a   Hernández, Frank ^a   Merino, Nelson ^b   Zamora, Zullyt ^a   Rojas, Enis ^a  

^a NATL CENTER FOR SCIENTIFIC RESEARCH   (Cuba)

^b Center of Pharmaceutical Chemistry Cuba   (Cuba)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CREATININE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; LIPID PEROXIDE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UREA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME LOCALIZATION; HISTOPATHOLOGY; KIDNEY FUNCTION; KIDNEY HOMOGENATE; LIPID PEROXIDATION; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; UREA BLOOD LEVEL;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; CISPLATIN; GLUTATHIONE; HUMANS; KIDNEY; KIDNEY DISEASES; LIPID PEROXIDES; MALE; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TISSUE EXTRACTS; UREA;

ANIMALIA;

EID: 25644436231     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/MI.2005.139     Document Type: Article

References (26)

1. Lebwohl D, Canetta R. Clinical development of platinum complexes in cancer therapy: an historical perspective and an update. Eur J Cancer. 1998;34(10):1522-1534.
2. Meyer KB, Madias NE. Cisplatin nephrotoxicity. Miner Electrolyte Metab. 1994;20(4):201-213.
3. Kersten L, Bräunlich H, Keppler BK, Gliesing C, Wendelin M, Westphal J. Comparative nephrotoxicity of some antitumour-active platinum and ruthenium complexes in rats. J Appl Toxicol. 1998;18(2):93-101.
4. Choie DD, Longnecker DS, del Campo AA. Acute and chronic cisplatin nephropathy in rats. Lab Invest. 1981;44(5):397-402.
5. Masuda H, Tanaka T, Takahama UT. Cisplatin generates superoxide anion by interaction with DNA in a cell-free system. Biochem Biophys Res Commun. 1994;203(2):1175-1180.
6. Baliga R, Zhang Z, Baliga M, Ueda N, Shah S. In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity. Kidney Int. 1998;53(2):394-401.
7. Matsushima H, Yonemura K, Ohishi K, Hishida A. The role of oxygen free radicals in cisplatininduced acute renal failure in rats. J Lab Clin Med. 1998;131(6):518-526.
8. Appenroth D, Fröb S, Kersten L, Splinter EK, Winnefeld K. Protective effects of vitamin E and C on cisplatin nephrotoxicity in developing rats. Arch Toxicol. 1997;71(11):677-683.
9. Zhang JG, Lindup WE. Role of mitochondria in cisplatin-induced oxidative damage exhibited by rat renal cortical slices. Biochem Pharmacol. 1993;45(11):2215-2222.
10. Trachtman H, Wilson D, Rao PS. The role of oxygen free radicals in the development of chronic renal failure. Life Sci. 1992;50(24):1877-1883.
11. Beutler F, Duron O, Mikus B. Improved method for the determination of blood glutathione. J Lab Clin Med. 1963;16(6):882-888.
12. Ohkawa H, Orishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95(2):351-358.
13. Minami M, Yoshikawa H. A simplified assay method of superoxide dismutase activity for clinical use. Clin Chim Acta. 1979;92(3):337-342.
14. Faraji B, Kang HK, Valentine JL. Methods compared for determining glutathione peroxidase activity in blood. Clin Chem. 1987;33(4):539-543.
15. Lowry OH, Rosebrough NJ, Far AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193(1):265-275.
16. Somani SM, Husain K, Whitworth C, Trammel GL, Malafa M, Rybak LP. Dose-dependent protection by lipoic acid against cisplatin-induced nephrotoxicity in rats: antioxidant defense system. Pharmacol Toxicol. 2000;86(5):234-241.
17. Saad SY, Al-Rikabi AC. Protection effects of taurine supplementation against cisplatin-induced nephrotoxicity in rats. Chemotherapy. 2002;48(1):42-48.
18. Davis CA, Nick HS, Agarwal A.Manganese superoxide dismutase attenuates cisplatin-induced renal injury: importance of superoxide. J Am Soc Nephrol. 2001;12(12):2683-2690.
19. Borrego A, Zamora ZB,González R, et al. Protection by ozone preconditioning is mediated by the antioxidant system in cisplatin-induced nephrotoxicity in rats. Mediators Inflamm. 2004;13(1):13-19.
20. Gonzalez R, Borrego A, Zamora ZB, et al. Reversion by ozone treatment of acute nephrotoxicity induced by cisplatin in rats. Mediators Inflamm. 2004;13(5-6):307-312.
21. Kruidering M, Van de Water B, De Heer E, Mulder GJ, Nagelkerke JF. Cisplatin-induced nephrotoxicity in porcine proximal tubular cells: mitochondrial dysfunction by inhibition of complexes I to IV of the respiratory chain. J Pharmacol Exp Ther. 1997;280(2):638-649.
22. Agarwal A, Nick HS. Renal response to tissue injury: lessons from heme oxygenase-1 gene ablation and expression. J Am SocNephrol. 2000;11(5):965-973.
23. Dennery PA. Regulation and role of heme oxygenase in oxidative injury. Curr Top Cell Regul. 2000;36:181-199.
24. Ohta K, Yachie A, Fujimoto K, et al. Tubular injury as a cardinal pathologic feature in human heme oxygenase-1 deficiency. Am J Kidney Dis. 2000;35(5):863-870.
25. Agarwal A, Balla J, Alam J, Croatt AJ, Nath KA. Induction of heme oxygenase in toxic renal injury: a protective role in cisplatin nephrotoxicity in the rat. Kidney Int. 1995;48(4):1298-1307.
26. Schaaf GJ, Maas RF, De Groene EM, Fink-Gremmels J. Management of oxidative stress by heme oxygenase-1 in cisplatin-induced toxicity in renal tubular cells. Free Radic Res. 2002;36(8):835-843.